Evidence map›Paper›PMID 41264208›Full record

ArticleHepatology international2026

Enhancing post-TIPS hepatic encephalopathy risk stratification: a hybrid TabPFN model leveraging radiomics, deep transfer learning features, and MELD score.

Lei Miao, He Zhao, Xiaowu Zhang, Jingui Li, Qing Peng, Yingen Luo, Pengfei Tian, Xuefeng Luo, Jun Tie, Xiao Li

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Hepatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Lei MiaoDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
He ZhaoDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Xiaowu ZhangDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Jingui LiDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Qing PengDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yingen LuoDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Pengfei TianDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Xuefeng LuoDepartment of Gastroenterology and Hepatology, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, 37 Guoxue Ln, Chengdu, 610041, China.
Jun TieState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, China. tiejun7776@163.com.
Xiao LiDepartment of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. simonlixiao@263.net.

Funding

Chinese Academy of Medical Sciences Initiative for Innovative Medicine 2021-I2M-1-015Chinese Academy of Medical Sciences Initiative for Innovative Medicine 2025-I2M-C&T-B-046Cooperation Fund of CHCAMS CFA202502018National Natural Science Foundation of China 82330061Science and Education Cultivation Fund of the National Cancer and Regional Medical Center of Shanxi Provincial Cancer Hospital TD2023003
6 · The paper itself

Abstract

purposePredicting hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) is critical for guiding portal hypertension treatment strategies and enabling early intervention. This study aims to employ the Tabular Prior-data Fitted Network (TabPFN) algorithm to develop a machine learning (ML) model that predicts post-TIPS HE.

methodsThis study retrospectively enrolled 218 patients who underwent TIPS across three hospitals. Preoperative contrast enhanced CT (CECT) scans were used to delineate the volumetric region of interest (VOI) for the liver, spleen, abdominal fat, and abdominal muscle. Radiomics and deep transfer learning (DTL) features were extracted from each VOI. Overt HE occurrence during follow-up was divided into two groups. 171 patients (two hospitals) were randomly split (7:3) into training and validation set, 47 patients (third hospital) formed an external test set. After feature selection, we trained and compared multiple ML models. Shapley additive explanation (SHAP) was performed for model interpretability.

resultsThe overall incidence of overt HE in the study cohort was 20.6%. The combined TabPFN model with the best predictive performance achieved AUCs of 0.953 (training set), 0.870 (validation set), and 0.942 (external test set), with accuracies of 0.933, 0.846, and 0.872, respectively. SHAP analysis identified the liver radiomics signature as a dominant predictors. Time-dependent AUCs at 90, 180, 365, and 730 days exceeded 0.88 in all cohorts, and high-risk patients had significantly higher HE occurrence (p < 0.01).

conclusionA TabPFN-based ML model integrating CECT radiomics, DTL features, and MELD score enables accurate, externally validated prediction of post-TIPS HE, supporting personalized risk stratification and clinical decision-making.

Indexed as

Deep LearningHepatic EncephalopathyPortasystemic Shunt, Transjugular IntrahepaticPostoperative ComplicationsAdultFemaleHumansHypertension, PortalMachine LearningMaleMiddle AgedRadiomicsRetrospective StudiesRisk AssessmentTomography, X-Ray ComputedDeep learningHepatic encephalopathyMachine learningRadiomicsTransjugular intrahepatic portosystemic shunt

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.